MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Prediction of turning characteristics parameters into Parkinson’s disease

    F. Khobkhun, A. Hirunkitti, T. Prasertsakul (Nakhon Pathom, Thailand)

    Objective: To investigate the parameters predicting turning dysfunction in individuals with Parkinson’s disease (PD). Background: Turning deficit in PD has significant implications particularly regarding increase…
  • 2023 International Congress

    Psychosocial factors impacting participation in a time-intensive deep brain stimulation study of individuals with Parkinson’s disease and dystonia

    A. Hahn, S. Cernera, C. Racine, S. Little, P. Starr (San Francisco, USA)

    Objective: To evaluate psychosocial factors impacting the number of hours of participation in the first five months of a time-intensive deep brain stimulation (DBS) study.…
  • 2023 International Congress

    Adverse Events of Opicapone Adjunctive Therapy in 60 Consecutive Patients

    T. Bo, Y. Hashimoto, T. Ichikawa (Saitama, Japan)

    Objective: This study aimed to investigate the risk of adverse events (AEs) when opicapone (OPC) was added as adjunctive therapy to L-dopa administration. Background: Levodopa…
  • 2023 International Congress

    monogenic parkinsonism in latin america: systematic review and meta-analysis

    P. Saffie-Awad, D. Texeira, P. Chana-Cuevas, A. Schumacher-Schuh (Santiago, Chile)

    Objective: This study aims to assess the frequency, distribution and the minimum prevalence of monogenic Parkinsonism in Latin America (LA) Background: The prevalence of monogenic…
  • 2023 International Congress

    Effects of ankle dorsiflexion training on anticipatory postural adjustments during gait initiation of patients with Parkinson’s disease

    A. Nagai, M. Okinishi, T. Kozuki, K. Ohata, S. Takasaki, H. Kojima, K. Marumoto (Hyogo, Japan)

    Objective: The purpose of this study was to investigate whether ankle dorsiflexion training (ADT) for patients with Parkinson’s disease (PD) may improve anticipatory postural adjustments…
  • 2023 International Congress

    An Open-Access Model for Parkinson’s Disease Progression

    S. Mosovsky, K. Saboo, K. Severson, A. Amini, L. Crawford, N. Yates, J. Adibi, L. Chahine (Pittsburgh, USA)

    Objective: To model the progression of PD by developing a hidden Markov model which incorporates nonlinear effects of disease severity and medication on clinical scores.…
  • 2023 International Congress

    Identifying a path to improve diagnostic delay and access to care for PSP, CBS, and MSA

    M. Bruno, F. Ali, M. Dale, M. Schmidt, M. Comeau, C. Spears, J. Shurer (Honolulu, USA)

    Objective: To understand diagnosis and care experiences of patients and care partners living with progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and multiple system atrophy…
  • 2023 International Congress

    A 20-year review of a Movement Disorders Database in Singapore

    YH. Nah, S. Neo, S. Ng, N. Chia, HL. Ng, W. Li, A. Zhan, KY. Tay, Z. Xu, WL. Au, L. Tan (Singapore, Singapore)

    Objective: To conduct a 20-year review of the movement disorders (MD) clinical database in Singapore. Background: MDs contribute to a significant portion of chronic disease…
  • 2023 International Congress

    MDS-UPDRS III Off Severity Level changes as a marker of DBS response

    S. Castillo-Torres, I. Cruz, M. Rossi, M. Wilken, D. Cerquetti, M. Merello (Buenos Aires, Argentina)

    Objective: To determine the change in MDS-UPDRS III severity level after Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) in patients with Parkinson’s disease (PD) and evaluate…
  • 2023 International Congress

    The prevalence of Parkinson’s disease in a predominantly rural area of North West England

    R. Varden, R. Walker, A. O'Callaghan (Carlilse, United Kingdom)

    Objective: To calculate the crude and age adjusted prevalence of Parkinson’s disease (PD) in North Cumbria. Background: Prevalence data give insight into disease cause and…
  • « Previous Page
  • 1
  • …
  • 128
  • 129
  • 130
  • 131
  • 132
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley